繁體
简体中文
繁體中文

undefined undefined

--

NaN.000

NaN.00%

华盛通華盛通
立即下載
  • 最 高--
  • 今 開--
  • 振 幅 NaN.00%
  • 最 低 --
  • 昨 收 --
  • 成交額 --

個股概要

財務分析

公司資料

相關新聞

分紅派息

  • 分時圖
  • 日k
  • 周k
  • 月k

相關新聞

更多
  • Take-Two beats Q3 revenue expectations, ups FY net bookings forecast

    Take-Two beats Q3 revenue expectations, ups FY net bookings forecast Overview Video game publisher's Q3 net bookings rose 28% to $1.76 bln, above co's guidance range Q3 GAAP net revenue was $1.70 bln, beating analysts' expectations Company raised fiscal year 2026 net bookings outlook to $6.65-$6.7 b

    02-04 05:15

  • BRIEF-MPLX LP Reports Q4 Results

    BRIEF-MPLX LP Reports Q4 Results Feb 3 (Reuters) - MPLX LP MPLX.N : MPLX Q4 NET INCOME USD 1,193 MILLION MPLX Q4 PRETAX PROFIT USD 1,206 MILLION MPLX Q4 INCOME FROM OPERATIONS USD 1,483 MILLION MPLX Q4 OPERATING EXPENSES USD 419 MILLION MPLX Q4 ADJUSTED EBITDA USD 1,804 MILLION VERSUS. IBES ESTIMATE

    02-03 21:19

  • UPDATE 1-AmEx projects upbeat 2026 profit as affluent spending holds up

    UPDATE 1-AmEx projects upbeat 2026 profit as affluent spending holds up AmEx sees 2026 profit, revenue largely above expectations CFO touts focus on younger and premium consumers Strong holiday shopping season boosts Q4 revenue Shares fall as investors digest marginal Q4 profit miss Rewrites through

    01-30 23:00

  • BUZZ-Street View: Mastercard in high gear following extended partnership with Capital One

    BUZZ-Street View: Mastercard in high gear following extended partnership with Capital One ** Mastercard MA.N beat Wall Street’s Q4 profit expectations on solid consumer spending and said it will cut about 4% of its global staff to shift investments ** Co said it extended its U.S. and Canada partners

    01-30 21:29

  • ALX Oncology Reports CD47 Biomarker Predicts Response to Evorpacept in Advanced HER2-Positive Breast Cancer

    ALX Oncology Reports CD47 Biomarker Predicts Response to Evorpacept in Advanced HER2-Positive Breast Cancer ALX Oncology Holdings Inc. has announced new data from a Phase 1b/2 clinical trial evaluating its investigational CD47-inhibitor evorpacept in combination with Jazz Pharmaceuticals' zanidatama

    01-30 21:15

  • UPDATE 4-Mastercard profit exceeds expectations, set to lay off 4% globally

    UPDATE 4-Mastercard profit exceeds expectations, set to lay off 4% globally Adds details on job cuts in paragraphs 1 to 4 By Utkarsh Shetti Jan 29 (Reuters) - Mastercard MA.N beat Wall Street expectations for fourth-quarter profit on resilient spending, and said it will lay off about 4% of its globa

    01-29 21:08

  • UPDATE 3-Mastercard profit beats estimates on sustained consumer spending

    UPDATE 3-Mastercard profit beats estimates on sustained consumer spending Updates with comparisons throughout Jan 29 (Reuters) - Mastercard MA.N beat Wall Street expectations for fourth-quarter profit on Thursday, as resilient spending on travel, leisure and everyday essentials boosted transaction v

    01-29 21:08

  • Tractor Supply Q4 sales miss estimates as discretionary demand softens

    Tractor Supply Q4 sales miss estimates as discretionary demand softens Overview Rural lifestyle retailer's Q4 net sales rose 3.3% but missed analyst expectations Q4 diluted EPS was $0.43, in line with previous year Company opened 31 new Tractor Supply stores and one new Petsense store in Q4 Outlook

    01-29 20:03

  • BRIEF-Presidio Property Trust Inc - Suspends Monthly Dividend On Series D Preferred Stock

    BRIEF-Presidio Property Trust Inc - Suspends Monthly Dividend On Series D Preferred Stock Jan 28 (Reuters) - Presidio Property Trust Inc SQFT.O : PRESIDIO PROPERTY TRUST INC - SUSPENDS MONTHLY DIVIDEND ON SERIES D PREFERRED STOCK - SEC FILING PRESIDIO PROPERTY TRUST INC - UNPAID DIVIDENDS TO ACCRUE

    01-29 07:09

  • Ethan Allen Interiors posts Q2 sales drop

    Ethan Allen Interiors posts Q2 sales drop Overview Interior design firm's fiscal Q2 net sales declined yr/yr, missing analyst expectations Adjusted EPS for fiscal Q2 beat analyst expectations Company announced regular quarterly cash dividend of $0.39 per share Outlook Company remains cautiously opti

    01-29 05:13